American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 258-264.e2, 1 February 2010

Glaucoma Surgery Decreases the Rates of Localized and Global Visual Field Progression

  • Francisco A. Folgar

      Affiliations

    • New York University School of Medicine, New York, New York
    • Manhattan Eye, Ear and Throat Hospital, New York, New York
  • ,
  • Carlos Gustavo V. de Moraes

      Affiliations

    • New York University School of Medicine, New York, New York
    • Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
  • ,
  • Tiago S. Prata

      Affiliations

    • Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
  • ,
  • Christopher C. Teng

      Affiliations

    • Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
    • New York Medical College, Valhalla, New York
  • ,
  • Celso Tello

      Affiliations

    • Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
    • New York Medical College, Valhalla, New York
  • ,
  • Robert Ritch

      Affiliations

    • Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
    • New York Medical College, Valhalla, New York
  • ,
  • Jeffrey M. Liebmann

      Affiliations

    • New York University School of Medicine, New York, New York
    • Einhorn Clinical Research Center, New York Eye and Ear Infirmary, New York, New York
    • Manhattan Eye, Ear and Throat Hospital, New York, New York
    • Corresponding Author InformationInquiries to Jeffrey M. Liebmann, New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003

Accepted 16 September 2009.

Purpose

Incisional glaucoma surgical procedures produce greater intraocular pressure (IOP) reduction and less IOP variability than medical treatment. We sought to determine the efficacy of glaucoma surgery in decreasing localized and global rates of visual field (VF) progression.

Design

Retrospective, interventional case series.

Methods

Subjects in the New York Glaucoma Progression Study with glaucomatous optic neuropathy, repeatable VF loss, and 10 or more Swedish interactive threshold algorithm standard VF examinations were assessed for eligibility. Patients who underwent successful glaucoma surgery (not requiring further surgical intervention and IOP < 18 mm Hg) in either eye and who were followed up for at least 2 years before and after surgery were enrolled. Automated pointwise linear regression analysis was used to calculate global and localized rates of progression before and after surgery. Eyes with other ocular conditions likely to affect the VF and an insufficient number of VF to create a slope before and after surgery were excluded. Comparisons were performed within the same eyes before and after surgery (Student paired t test).

Results

We enrolled 28 eyes of 28 patients (mean age, 61.2 ± 14.5 years). The mean number ± standard deviation of VF was 13.4 ± 2.3, spanning 7.1 ± 1.2 years (range, 4 to 9 years). Mean IOP ± standard deviation decreased from 19.0 ± 3.9 mm Hg before surgery to 11.3 ± 3.7 mm Hg after surgery (40% reduction; P < .01). Mean global progression rates decreased from −1.48 ± 1.4 dB/year before surgery to −0.43 ± 0.8 dB/year after surgery (70% reduction; P = .01). Twelve eyes (42.8%) had at least 1 significantly progressing point before surgery, whereas only 2 (7.1%) had at least 1 progressing point after surgery. Each 1 mm Hg of IOP reduction after surgery resulted in a 0.1 dB/year decrease in the global rate of progression.

Conclusions

Successful IOP reduction after glaucoma surgery greatly reduces both the number of progressing points and the localized and general rates of VF progression.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9394(09)00723-5

doi:10.1016/j.ajo.2009.09.010

American Journal of Ophthalmology
Volume 149, Issue 2 , Pages 258-264.e2, 1 February 2010